Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
We outline common circumstances where index funds may be preferable to ETFs, including buy-and-hold strategies and simplicity.
25,141 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Taylor Swift and Travis Kelce announced a $26 million donation to 20 charities this week, fueling talk of a Friday Ma...
Marvell Technology has bold dreams about joining the trillion-dollar club. This article lays out a practical timeline...
A vacancy in Mitch McConnell’s Senate seat could trigger a rapid political clock in Kentucky, forcing a special elect...
A high-profile wedding draws attention—and wallets. This feature explores what Kylie Kelce calls Taylor Swift’s weddi...
New research finds america pays workers just a fraction of the country’s wealth, a share that trails most OECD peers ...
As the 2026 World Cup unfolds, France stands to collect a sizable prize pot regardless of results. Meanwhile, Mbappé ...
Rising gray divorces are reshaping retirement planning. Some ex-spouses may claim up to 50% of the other’s Social Sec...
A veteran journalist outlines Elliott Investment Management’s influence on Norwegian Cruise Line amid a strong cruise...
Cuba warns that an intensifying oil embargo is pushing its health system toward collapse, threatening everyday safety...
ServiceNow has faced a brutal market sell-off in 2026. This guide breaks down whether the decline creates a compellin...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...